Take2 Health is Honoured to be Awarded in the 2021 Inaugural SportsHour Company Scheme
Take2 Health is honoured to receive the Inaugural SportsHour Company Scheme Award which is organised by the InspiringHK Sports Foundation.
To foster a healthy lifestyle as part of the company culture in which one of the benefits is improving business efficiency, the scheme encourages Hong Kong companies and organisations to advocate to employees and their family members to exercise daily for an hour or more in mid-to-high-intensity as recommended by the World Health Organization. Echoing this initiative, our company encourages all our employees, families and friends to exercise regularly to stay fit. Furthermore, we envision raising citizens’ well-being by advocating health awareness on many aspects, such as cancers.
To truly achieve our vision and serve, help and protect those we care for, we are determined to provide excellent services with pioneering early cancer detection technologies and supply actionable cancer-related information to safeguard the long-term health of all human beings.
More Latest News
Nasopharyngeal Cancer Screening Results May “Predict” Development of Related Cancer and Improve Early Diagnosis, CUHK Study Finds
A recent study conducted by The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) has shown that individuals with detectable plasma Epstein–Barr virus (EBV) DNA but without an immediately identifiable nasopharyngeal cancer (NPC) after further investigation with nasal endoscopic examination and magnetic resonance imaging (MRI), have a higher risk of developing NPC in 3 to 5 years, up to 17 times higher than those tested “negative” in the test. The non-invasive liquid biopsy techniques not only could be used for early cancer detection but may also indicate the risk for future cancer development.
Promoting NPC Awareness across the City
Joining Hands with Bowtie to Sponsor the Take2 Prophecy™ Test for Nasopharyngeal Cancer to the High-risk Group
Awarded as The Company with the Most Investment Potential & The Top Breakthrough Innovation
Take2 Health are privileged to have participated in the first ZAODX World Conference on Early Detection of Cancer, and are very honoured to be awarded as The Company with the Most Investment Potential (金篩獎‧最具投資價值潛力企業) as well as The Top Breakthrough Innovation (金篩獎‧突破性創新獎)
